Private equity firm FIMI Opportunity Funds, headed by Ishay Davidi, has sold 33% of the shares in healthcare company Simplivia to The Phoenix Holdings Ltd. (TASE: PHOE1;PHOE5) and Leumi Partners, in equal shares, for $47 million, at a company valuation of $140 million. FIMI bought the business from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and set up Simplivia in 2019 at an investment of $47.5 million. Including the current deal, FIMI has made a return of $67 million on its investment. It will continue to hold 65% of the company. RELATED ARTICLES FIMI gains in space, aviation holdings lose altitude US co buys Oxygen & Argon from FIMI for NIS 575m FIMI to raise NIS 1.2b seventh fund FIMI doubles stake in Kamada with $25m investment Simplivia produces equipment that protects hospital medical staff from exposure to dangerous materials while treating oncology patients. Its production facility is in Kiryat Shemona and its head office is in Hod Hasharon. It employs about 200 people. Published by Globes, Israel business news - en.globes.co.il - on October 22, 2020 © Copyright of Globes Publisher Itonut (1983) Ltd. 2020
